AGF Investments LLC’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.7M | Buy |
16,003
+5,101
| +47% | +$542K | 0.16% | 37 |
|
|
2022
Q2 | $1.06M | Buy |
10,902
+1,329
| +14% | +$130K | 0.1% | 39 |
|
|
2022
Q1 | $897K | Buy |
+9,573
| New | +$897K | 0.07% | 119 |
|
|
2021
Q1 | – | Sell |
-7,766
| Closed | -$744K | – | 478 |
|
|
2020
Q4 | $744K | Sell |
7,766
-4,505
| -37% | -$432K | 0.09% | 203 |
|
|
2020
Q3 | $1.18M | Buy |
12,271
+2,306
| +23% | +$222K | 0.13% | 209 |
|
|
2020
Q2 | $1.22M | Buy |
9,965
+1,748
| +21% | +$213K | 0.12% | 177 |
|
|
2020
Q1 | $711K | Buy |
8,217
+890
| +12% | +$77K | 0.09% | 169 |
|
|
2019
Q4 | $788K | Buy |
7,327
+2,724
| +59% | +$293K | 0.15% | 301 |
|
|
2019
Q3 | $415K | Buy |
+4,603
| New | +$415K | 0.1% | 317 |
|
|
2018
Q4 | – | Sell |
-215
| Closed | -$27K | – | 776 |
|
|
2018
Q3 | $27K | Sell |
215
-149
| -41% | -$18.7K | ﹤0.01% | 494 |
|
|
2018
Q2 | $36 | Sell |
364
-428
| -54% | -$42 | ﹤0.01% | 495 |
|
|
2018
Q1 | $66K | Buy |
792
+306
| +63% | +$25.5K | 0.01% | 279 |
|
|
2017
Q4 | $38K | Buy |
+486
| New | +$38K | 0.01% | 292 |
|